# COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

> **NCT05046002** · — · RECRUITING · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 400 (estimated)

## Conditions studied

- Myocarditis
- Pericarditis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05046002
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-11
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05046002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05046002, "COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05046002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*